USD 2.53
(-5.87%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -8.04 Million USD | -166.57% |
2022 | -3.01 Million USD | 72.06% |
2021 | -10.8 Million USD | 7.24% |
2020 | -11.64 Million USD | -139.58% |
2019 | -4.86 Million USD | 48.2% |
2018 | -9.38 Million USD | -152.94% |
2017 | -3.71 Million USD | 23.28% |
2016 | -4.83 Million USD | -332.95% |
2015 | 2.07 Million USD | -20.0% |
2014 | 2.59 Million USD | 133.44% |
2013 | -7.76 Million USD | -47.38% |
2012 | -5.26 Million USD | -5.32% |
2011 | -5 Million USD | -84018.44% |
2010 | -5944.00 USD | -20.69% |
2009 | -4925.00 USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -27.06 Million USD | -241.42% |
2024 Q1 | -7.92 Million USD | 1.48% |
2023 Q3 | -12.8 Million USD | -26.09% |
2023 FY | -8.04 Million USD | -166.57% |
2023 Q1 | -2.73 Million USD | 9.54% |
2023 Q2 | -10.15 Million USD | -272.05% |
2023 Q4 | -8.04 Million USD | 37.18% |
2022 Q2 | -4.61 Million USD | 31.13% |
2022 Q3 | -2.25 Million USD | 51.14% |
2022 Q4 | -3.01 Million USD | -33.72% |
2022 Q1 | -6.7 Million USD | 37.92% |
2022 FY | -3.01 Million USD | 72.06% |
2021 Q4 | -10.8 Million USD | 8.58% |
2021 FY | -10.8 Million USD | 7.24% |
2021 Q3 | -11.81 Million USD | 70.53% |
2021 Q2 | -40.1 Million USD | 6.21% |
2021 Q1 | -42.75 Million USD | -267.16% |
2020 Q1 | -2.23 Million USD | 54.12% |
2020 Q2 | -13.01 Million USD | -483.45% |
2020 FY | -11.64 Million USD | -139.58% |
2020 Q3 | -9.6 Million USD | 26.15% |
2020 Q4 | -11.64 Million USD | -21.21% |
2019 Q3 | -6.1 Million USD | -63.71% |
2019 Q4 | -4.86 Million USD | 20.35% |
2019 FY | -4.86 Million USD | 48.2% |
2019 Q1 | -4.66 Million USD | 50.25% |
2019 Q2 | -3.72 Million USD | 20.15% |
2018 Q4 | -9.38 Million USD | 16.56% |
2018 Q3 | -11.24 Million USD | -74.59% |
2018 FY | -9.38 Million USD | -152.94% |
2018 Q1 | -4.63 Million USD | -24.99% |
2018 Q2 | -6.44 Million USD | -38.93% |
2017 Q2 | -6.87 Million USD | 19.75% |
2017 Q1 | -8.57 Million USD | -77.25% |
2017 Q3 | -4.76 Million USD | 30.73% |
2017 Q4 | -3.71 Million USD | 22.14% |
2017 FY | -3.71 Million USD | 23.28% |
2016 Q1 | 2.29 Million USD | 10.55% |
2016 FY | -4.83 Million USD | -332.95% |
2016 Q4 | -4.83 Million USD | 29.02% |
2016 Q2 | 3.03 Million USD | 32.2% |
2016 Q3 | -6.81 Million USD | -324.56% |
2015 Q1 | -5.13 Million USD | -298.03% |
2015 Q4 | 2.07 Million USD | 968.62% |
2015 Q3 | -239 Thousand USD | 90.79% |
2015 Q2 | -2.59 Million USD | 49.52% |
2015 FY | 2.07 Million USD | -20.0% |
2014 Q2 | 935 Thousand USD | 124.23% |
2014 FY | 2.59 Million USD | 133.44% |
2014 Q1 | -3.85 Million USD | 0.0% |
2014 Q4 | 2.59 Million USD | -45.18% |
2014 Q3 | 4.73 Million USD | 406.31% |
2013 FY | -7.76 Million USD | -47.38% |
2013 Q2 | -8.35 Million USD | -271.61% |
2013 Q3 | -4.05 Million USD | 51.49% |
2013 Q1 | 4.87 Million USD | 373.83% |
2012 Q4 | 1.02 Million USD | 138.62% |
2012 Q3 | -2.66 Million USD | 49.43% |
2012 FY | -5.26 Million USD | -5.32% |
2012 Q1 | -3.35 Million USD | 32.98% |
2012 Q2 | -5.26 Million USD | -57.09% |
2011 Q1 | -8.16 Million USD | -90711011.11% |
2011 FY | -5 Million USD | -84018.44% |
2011 Q2 | -7.8 Million USD | 4.43% |
2011 Q3 | -7.3 Million USD | 6.41% |
2011 Q4 | -5 Million USD | 31.53% |
2010 Q1 | -16.85 Thousand USD | 0.0% |
2010 Q2 | -5944.00 USD | 64.74% |
2010 Q3 | -944.00 USD | 84.12% |
2010 FY | -5944.00 USD | -20.69% |
2010 Q4 | -9.00 USD | 99.05% |
2009 Q2 | -4925.00 USD | 0.0% |
2009 FY | -4925.00 USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 27.08 Million USD | 129.706% |
BrainsWay Ltd. | -10.32 Million USD | 22.045% |
Cerus Corporation | 84.35 Million USD | 109.537% |
Envoy Medical, Inc. | -3.81 Million USD | -110.933% |
electroCore, Inc. | -9.95 Million USD | 19.186% |
Helius Medical Technologies, Inc. | -5.12 Million USD | -56.976% |
IceCure Medical Ltd | -9.93 Million USD | 19.016% |
Inogen, Inc. | -103.56 Million USD | 92.232% |
OrthoPediatrics Corp. | -9.26 Million USD | 13.187% |
Lucid Diagnostics Inc. | -3.64 Million USD | -120.956% |
Monogram Orthopaedics, Inc. | -13.09 Million USD | 38.574% |
MaxCyte, Inc. | -27.76 Million USD | 71.023% |
NeuroOne Medical Technologies Corporation | -5.13 Million USD | -56.576% |
Nexalin Technology, Inc. | -575.76 Thousand USD | -1297.267% |
Orthofix Medical Inc. | 96.44 Million USD | 108.342% |
PAVmed Inc | 29.08 Million USD | 127.659% |
Rapid Micro Biosystems, Inc. | -16.93 Million USD | 52.506% |
RxSight, Inc. | -6.68 Million USD | -20.434% |
Sight Sciences, Inc. | -102.71 Million USD | 92.168% |
SI-BONE, Inc. | 5.72 Million USD | 240.622% |
TELA Bio, Inc. | -3.94 Million USD | -103.722% |
Treace Medical Concepts, Inc. | 57.32 Million USD | 114.035% |
Vivos Therapeutics, Inc. | 352 Thousand USD | 2385.511% |
Acutus Medical, Inc. | 12.27 Million USD | 165.518% |
Talis Biomedical Corporation | -57.06 Million USD | 85.902% |
Spectral AI, Inc. | -3.5 Million USD | -129.791% |
Nano-X Imaging Ltd. | -48.02 Million USD | 83.249% |
CVRx, Inc. | -59.95 Million USD | 86.582% |
DIH Holding US, Inc. Warrants | 1.98 Million USD | 505.464% |
PetVivo Holdings, Inc. | 1.27 Million USD | 729.678% |
Bioventus Inc. | 372.51 Million USD | 102.16% |
Venus Concept Inc. | 74.3 Million USD | 110.828% |
TriSalus Life Sciences, Inc. | -10.18 Million USD | 20.988% |
LivaNova PLC | 62.53 Million USD | 112.865% |
908 Devices Inc. | -115.09 Million USD | 93.01% |
Alphatec Holdings, Inc. | 320.7 Million USD | 102.509% |
Nemaura Medical Inc. | 9.92 Million USD | 181.058% |
NeuroPace, Inc. | 54.33 Million USD | 114.806% |
LENSAR, Inc. | -18.31 Million USD | 56.067% |
Apyx Medical Corporation | -5.15 Million USD | -56.183% |
Cutera, Inc. | 288.3 Million USD | 102.79% |
STRATA Skin Sciences, Inc. | 7.51 Million USD | 207.053% |
BioSig Technologies, Inc. | 262 Thousand USD | 3170.611% |
Anika Therapeutics, Inc. | -43.83 Million USD | 81.645% |
ClearPoint Neuro, Inc. | -9.19 Million USD | 12.545% |
Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.572% |
Axonics, Inc. | -77.19 Million USD | 89.578% |
Outset Medical, Inc. | 67.67 Million USD | 111.887% |
IRIDEX Corporation | -4.28 Million USD | -87.617% |
PROCEPT BioRobotics Corporation | -178.01 Million USD | 95.481% |
IRadimed Corporation | -47.71 Million USD | 83.141% |
Tivic Health Systems, Inc. | -3.02 Million USD | -165.863% |
INVO Bioscience, Inc. | 8.45 Million USD | 195.194% |
Telesis Bio, Inc. | 32.63 Million USD | 124.651% |
Viemed Healthcare, Inc. | -2.5 Million USD | -221.526% |
Varex Imaging Corporation | 316.9 Million USD | 102.539% |
Quipt Home Medical Corp. | 81.73 Million USD | 109.843% |
Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -189.18% |
Pulmonx Corporation | -42.36 Million USD | 81.008% |
Dynatronics Corporation | 6.2 Million USD | 229.674% |
Modular Medical, Inc. | -8.04 Million USD | -0.037% |
ReShape Lifesciences Inc. | -4.29 Million USD | -87.224% |
Semler Scientific, Inc. | -57.13 Million USD | 85.918% |
InMode Ltd. | -135.39 Million USD | 94.058% |
Bruker Corporation | 891.3 Million USD | 100.903% |
Cytosorbents Corporation | 4.18 Million USD | 292.371% |
DexCom, Inc. | 2.02 Billion USD | 100.397% |
Align Technology, Inc. | -840.47 Million USD | 99.043% |
Viveve Medical, Inc. | -13.81 Million USD | 41.758% |
ZimVie Inc. | 450.41 Million USD | 101.786% |
Movano Inc. | -5.86 Million USD | -37.146% |
Cytek Biosciences, Inc. | -134.45 Million USD | 94.017% |
Nexalin Technology, Inc. | -575.76 Thousand USD | -1297.267% |
DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 505.464% |
Tandem Diabetes Care, Inc. | 356.79 Million USD | 102.255% |
Profound Medical Corp. | -18.17 Million USD | 55.744% |
Insulet Corporation | 798.1 Million USD | 101.008% |
enVVeno Medical Corporation | -2.21 Million USD | -262.714% |
Surmodics, Inc. | -12.01 Million USD | 33.036% |
iCAD, Inc. | -21.2 Million USD | 62.068% |
Nuwellis, Inc. | -2.81 Million USD | -185.385% |
Biotricity, Inc. | 23.09 Million USD | 134.838% |
iRhythm Technologies, Inc. | 93.65 Million USD | 108.59% |
Aethlon Medical, Inc. | -4.5 Million USD | -78.712% |
PAVmed Inc. | 29.08 Million USD | 127.659% |
BIOLASE, Inc. | 11.34 Million USD | 170.919% |
Beyond Air, Inc. | 6.22 Million USD | 229.154% |
FONAR Corporation | -14.66 Million USD | 45.143% |
AxoGen, Inc. | 32.26 Million USD | 124.933% |
Vivani Medical, Inc. | 42 Thousand USD | 19254.762% |
Tactile Systems Technology, Inc. | -10.65 Million USD | 24.517% |
Inari Medical, Inc. | -7.16 Million USD | -12.345% |
UFP Technologies, Inc. | 40.77 Million USD | 119.731% |
QT Imaging Holdings, Inc. | 3.06 Million USD | 362.17% |
Heart Test Laboratories, Inc. | -4.77 Million USD | -68.612% |
Tenon Medical, Inc. | -1.25 Million USD | -541.036% |
Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -5.772% |
Co-Diagnostics, Inc. | -11.92 Million USD | 32.544% |
AdaptHealth Corp. | 2.21 Billion USD | 100.363% |
Sintx Technologies, Inc. | 905 Thousand USD | 988.95% |
NanoVibronix, Inc. | -3.27 Million USD | -145.424% |
Quanterix Corporation | -132.95 Million USD | 93.949% |
Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -189.18% |
Sensus Healthcare, Inc. | -22.36 Million USD | 64.029% |
Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.067% |
TransMedics Group, Inc. | 121.13 Million USD | 106.641% |
ReWalk Robotics Ltd. | -26.18 Million USD | 69.27% |
NeuroMetrix, Inc. | -1.49 Million USD | -439.545% |
Hyperfine, Inc. | -75.61 Million USD | 89.361% |
Establishment Labs Holdings Inc. | 152.18 Million USD | 105.286% |
Biomerica, Inc. | -3.38 Million USD | -137.666% |
Bone Biologics Corporation | -3.02 Million USD | -165.813% |
AVITA Medical, Inc. | -26.23 Million USD | 69.331% |
Bluejay Diagnostics, Inc. | -1.83 Million USD | -337.606% |
Silk Road Medical, Inc | 64.42 Million USD | 112.488% |